Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_assertion type Assertion NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_head.
- NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_assertion description "[Allogeneic SCT is important in myelodysplastic syndrome, the BCR-ABL-negative chronic myeloproliferative diseases (CMPDs) and in poor-risk AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_provenance.
- NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_assertion evidence source_evidence_literature NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_provenance.
- NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_assertion SIO_000772 18587431 NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_provenance.
- NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_assertion wasDerivedFrom befree-20140225 NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_provenance.
- NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_assertion wasGeneratedBy ECO_0000203 NP542004.RApBosatV9ZOFlFjaCROk9vhnSc0FOWar13PQiXfKEfC8130_provenance.